SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news

 

 
News in brief

GSK to move Philly ops to $81m facility

10-Feb-2011
Last updated on 10-Feb-2011 at 12:51 GMT

GSK has unveiled plans to move its operations in Philadelphia to a purpose built facility due to be constructed at a former US Navy shipyard.

The new $81m (€59m) building, work on which is scheduled to start later this month, will be a replacement for GlaxoSmithKline’s (GSK) current Philadelphia base in the city centre.

The building is intended to provide an open-plan environment to boost cross departmental interaction. It is also designed achieve LEED Platinum certification, which is an internationally recognized standard for building sustainability.

A GSK spokeswoman told in-PharmaTechnologist that the facility will house the firm’s pharmaceuticals, consumer healthcare businesses and support functions and will employ around 1,300 people.

She explained that: “GSK is slowly transitioning all its facilities to an open plan. In the facilities where GSK has adopted open plan space, employee collaboration, access to decision makers, communication, and group effectiveness have improved significantly.

The UK-based drugmaker also told Dow Jones newswires the 205,000sqft open plan facility could save it as much as $26m a year when fully operational in late 2012 or early 2013.

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions